Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles

International Journal of Pharmaceutics

Volumn 368, Issue 1-2, 2009, Pages 154-159

  Owen, Heather ^a   Graham, Sabine ^a   Werling, Jane O ^a   Carter, Phillip W ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Hydrophobicity; Stability; Surface charge; Surfactant; Zeta potential

Indexed keywords

ANION; BUDESONIDE; CETRIMIDE; ITRACONAZOLE; POLOXAMER; POLYSORBATE 80; SULFONIC ACID DERIVATIVE; WATER;

ADSORPTION; ALKALINITY; ARTICLE; CALCULATION; DRUG SOLUBILITY; DRUG STABILITY; ELECTRICITY; HYDROPHOBICITY; PREDICTION; PRIORITY JOURNAL; PROTON TRANSPORT; SOLUBILITY; STEREOSPECIFICITY; ZETA POTENTIAL;

ADSORPTION; ANIONS; BUDESONIDE; CRYSTALLIZATION; DRUG COMPOUNDING; DRUG STABILITY; ELECTROCHEMISTRY; HYDROPHOBICITY; ITRACONAZOLE; PARTICLE SIZE; POLOXAMER; POLYSORBATES; SOLUBILITY; STATIC ELECTRICITY; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; SUSPENSIONS;

EID: 59249101690     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.10.004     Document Type: Article

References (27)

1. Akers M.J., Fites A.L., and Robinson R.L. Formulation design and development of parenteral suspensions. J. Parenteral Sci. Technol. 41 (1987) 88-96
2. Bergman L., Rosenholm J., Ost A.-B., Duchanoy A., Kankaanpaa P., Heino J., and Linden M. On the complexity of electrostatic suspension stabilization of functionalized silica nanoparticles for biotargeting and imaging applications. J. Nanomater. (2008) 10.1155/2008/712514
3. Chaubal M.V., Rabinow B.E., and Kipp J.E. Excipient selection and criteria for injectable dosage forms. In: Katdare A., and Chaubal M.V. (Eds). Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems (2006), Informa Healthcare, New York 271-290
4. Deryaguin B.V., and Landau L.D. Acta Physicochim. USSR 14 (1941) 633
5. Evans R., Davison J.B., and Napper D.H. The preparation of aqueous entropically stabilized latices. J. Polym. Sci. B 10 (1972) 449
6. Griffin W.C. Calculation of HLB values of non-ionic surfactants. J. Soc. Cosmet. Chem. 5 (1954) 249-256
7. Huang G., Gao J., Zhibing H., St. John J.V., Ponder B.C., and Moro D. Controlled drug release from hydrogel nanoparticle networks. J. Control. Rel. 94 (2004) 303-311
8. Hunter R.J. Foundations of Colloid Science. 2nd ed. (2001), Oxford University Press, New York, USA p. 377
9. Jodar-Reyes A.B., Ortega-Vinuesa J.L., and Martin-Rodriguez A. Electrokinetic behavior and colloidal stability of polystyrene latex coated with ionic surfactants. J. Colloid Interface Sci. 297 (2006) 170-181
10. Kesisoglou F., Panmai S., and Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59 (2007) 631-644
11. Klopman G., Wang S., and Balthasar D.M. Estimation of aqueous solubility of organic molecules by the group contribution approach. Application to the study of biodegradation. J. Chem. Inf. Comput. Sci. 32 (1992) 474-482
12. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18 (2003) 113-120
13. Moghimi S.M. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block copolymers. Adv. Drug Deliv. Rev. 16 (1995) 183-193
14. Muller R.H., and Bohm B.H.L. In: Muller R.H., et al. (Ed). Nanosuspensions. Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs (1998), Medpharm Scientific Publications, Stuttgart
15. Myers D. Surfactant Science and Technology. 3rd ed. (2006), John Wiley and Sons, Hoboken, NJ
16. Napper D.H. Colloid stability. I&EC Prod. Res. Dev. 9 (1970) 467
17. Ng S.S.W., Sparreboom A., Shaked Y., Lee C., Man S., Desai N., Soon-Shiong P., Figg W.D., and Kerbel R.S. Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus Cremophor EL-based paclitaxel. Clin. Cancer Res. 12 (2006) 4331-4338
18. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 3 (2004) 785-796
19. Rieger M.M. Surfactants. In: Lieberman H.A., et al. (Ed). Pharmaceutical Dosage Forms: Disperse Systems. 2nd ed. vol. 1 (1996), Marcel Dekker, New York 91-152
20. Romero-Cano M.S., Martin-Rodriquez A., Chauveteau G., and Nieves F.J. Colloidal stabilization of polystyrene particles by adsorption of nonionic surfactant. II. Electrosteric stability studies. J. Colloid Interface Sci. 198 (1998) 273-281
21. Sahiner N., Alb A.M., Graves R., Mandal T., McPherson G.L., Reed W.F., and John V.T. Core-shell nanohydrogel structures as tunable delivery systems. Polymer 48 (2007) 704-711
22. Stenkamp V.S., McGuiggan P., and Berg J.C. Restabilization of electrosterically stabilized colloids in high salt media. Langmuir 17 (2001) 637-651
23. Verwey E.J.W., and Overbeek J.T.G. Theory of the Stability of Lyophobic Colloids (1948), Elsevier, New York
24. Viswanadhan V.N., Ghose A.K., Revankar G.R., and Robins R.K. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occuring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 29 (1989) 163-172
25. Washington C., and Davis S.S. Ageing effects in parenteral fat emulsions: the role of fatty acids. Int. J. Pharm. 39 (1987) 33-37
26. Werling J., Graham S., Owen H., Nair L., Gonyon T., and Carter P.W. Physicochemical stability of phospholipid-dispersed suspensions of crystalline itraconazole. Eur. J. Pharmaceut. Biopharmaceut. 69 (2008) 1104-1113
27. Wissing S.A., Kayser O., and Muller R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 1257-1272